Matching slides 19,048
Current window 6,391-6,420
Pages 635
Rows per page 30
Slide type: Otherclear collectionreset all

Slide type

6,391-6,420 of 19,048

filter-aware
85
The slide uses a process flow diagram to explain the biological mechanism of action.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
87
The slide uses a linear process flow to explain the biological mechanism of the drug.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
92
The slide uses a biological process flow diagram to explain the therapeutic rationale.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
98
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
102
The slide uses a diagram to illustrate the biological pathway from IL-12 to immune cell activation and subsequent downstream effects.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
106
The slide shows two line charts comparing tumor and blood concentration over time for two different subunits.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
107
The slide shows significantly higher accumulation of targeted subunits compared to non-targeted IL-12 in murine CT-26 tumor models.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
113
Scientific illustration of neurobiology concepts.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
115
The slide uses a biological mechanism diagram to explain the therapeutic rationale for HDAC inhibitors.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
116
The slide uses a phylogenetic-style tree to categorize HDACs and a cluster diagram to show protein complex composition.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
117
Scientific presentation slide detailing molecular binding mechanism.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
21
This slide serves as a brand-building or cultural-relevance proof point.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank Loop · Golden Circle1 hit
47
The slide highlights the sponsor's (Vistas Media) expertise across media, finance, and governance.Anghami | SPAC Presentation Deck | 48 slides · Anghami
Pitch deck Investment bank Beat · Team1 hit
13
The slide uses a simple arithmetic flow to define 'Net Investment Spread' and lists four key benefits of the model.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Problem & Complication1 hit
20
The circular diagram acts as a hub-and-spoke or ecosystem visualization of business units.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Solution & ApproachLoop · Anchor1 hit
27
The slide highlights the addition of 'Retirement Services' in the pro forma structure with a blue circle annotation.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Solution & Approach1 hit
09
The slide outlines the dosing schedule (weeks 1-4, 5-16, and beyond) and the primary objective for the trials.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
10
The slide uses a process flow diagram to illustrate the clinical trial protocol.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
11
The slide uses a flow-based diagram to map disease indications to franchises, using checkmarks to indicate proof-of-concept.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 1 hit
12
The slide uses a biological pathway diagram to illustrate the mechanism of action.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 1 hit
14
The diagram uses a hub-and-spoke model to represent the flow of innovation.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 1 hit
16
The slide uses a three-column layout to present different community-facing assets.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 1 hit
17
The slide uses a split-screen layout to contrast US regulatory progress with global (Japan, EU, China) filing expectations.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 1 hit
17
The slide uses a grid-based categorization of drug modalities.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
19
The slide uses a combination of process flow, microscopy imagery, and a bar chart to demonstrate the therapeutic potential of HVP cells.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
23
The slide uses a color-coded grid to distinguish between highlighted pipeline assets and others, with extensive footnotes detailing specific drug mechanisms and disease targets.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
The slide combines a biological mechanism diagram with two bar charts showing clinical efficacy data.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
55
Includes a screenshot of a meeting interface toolbar.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
64
The slide uses a combination of a biological pathway diagram and a violin plot to demonstrate drug efficacy.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
69
AstraZeneca | Investor Day Presentation Deck | 86 slidesAstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit